Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/142173| Título: | Astrazeneca equity research - adapting to a dynamic pharmaceutical sector as a key to success |
| Autor: | Papp, Alexander |
| Orientador: | André, Rosário |
| Palavras-chave: | Valuation Finance Astrazeneca Pharmaceuticals |
| Data de Defesa: | 13-Jan-2022 |
| Resumo: | This master thesis analyzes AstraZeneca’s business model as well as competitive positioning in a dynamic pharmaceutical sector and provides an in-depth analysis of the company’s financial performance. By analyzing the firm’s strategy and core strengths and weaknesses compared to its competition, we are able to forecast its future performance. The goal of this thesis is to derive the fair value of AstraZeneca in the context of a transforming pharmaceutical business model. |
| URI: | http://hdl.handle.net/10362/142173 |
| Designação: | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics |
| Aparece nas colecções: | NSBE: Nova SBE - MA Dissertations |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| 28859_alexander_papp_astrazeneca_equity_research_-_adapting_to_a_dynamic_pharmaceutical_sector_as_a_key_to_success_211803_2049685785.pdf | 3,48 MB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.
